Indication

Menkes Disease

Menkes disease is a rare, X-linked recessive neurodegenerative disorder of copper metabolism caused by pathogenic variants in the *ATP7A* gene. Read more about Menkes Disease

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Menkes Disease therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Menkes Disease preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Menkes Disease.

Menkes disease is a rare, X-linked recessive neurodegenerative disorder of copper metabolism caused by pathogenic variants in the *ATP7A* gene.

This genetic defect disrupts intestinal copper absorption and intercellular transport, causing profound intracellular copper deficiency across the central nervous system, connective tissues, and vasculature, primarily affecting infant males.

Patients typically present in early infancy with failure to thrive, progressive neurodevelopmental regression, hypotonia, intractable seizures, autonomic instability, and distinctive sparse, fragile, "steely" or kinky hair.

Secondary to impaired activity of copper-dependent enzymes, the disease leads to severe cerebral atrophy, subdural hematomas, and arterial tortuosity, typically resulting in early childhood mortality without early therapeutic intervention.

Personalize your experience

Follow Menkes Disease and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it